Literature DB >> 19146393

Reaction of Mycobacterium tuberculosis cytochrome P450 enzymes with nitric oxide.

Hugues Ouellet1, Jérôme Lang, Manon Couture, Paul R Ortiz de Montellano.   

Abstract

During the initial growth infection stage of Mycobacterium tuberculosis (Mtb), (*)NO produced by host macrophages inhibits heme-containing terminal cytochrome oxidases, inactivates iron/sulfur proteins, and promotes entry into latency. Here we evaluate the potential of (*)NO as an inhibitor of Mtb cytochrome P450 enzymes, as represented by CYP130, CYP51, and the two previously uncharacterized enzymes CYP125 and CYP142. Using UV-visible absorption, resonance Raman, and stopped-flow spectroscopy, we investigated the reactions of (*)NO with these heme proteins in their ferric resting form. (*)NO coordinates tightly to CYP125 and CYP142 (submicromolar) and with a lower affinity (micromolar) to CYP130 and CYP51. Anaerobic reduction of the ferric-NO species with sodium dithionite led to the formation of two spectrally distinct classes of five-coordinate ferrous-NO complexes. Exposure of these species to O(2) revealed that the ferrous-NO forms of CYP125 and CYP142 are labile and convert back to the ferric state within a few minutes, whereas ferrous CYP130 and CYP51 bind (*)NO almost irreversibly. This work clearly indicates that, at physiological concentrations (approximately 1 microM), (*)NO would impair the activity of CYP130 and CYP51, whereas CYP125 and CYP142 are more resistant. Selective P450 inhibition may contribute to the inhibitory effects of (*)NO on Mtb growth.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19146393      PMCID: PMC2681326          DOI: 10.1021/bi801595t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  50 in total

1.  Identification of Mycobacterial genes that alter growth and pathology in macrophages and in mice.

Authors:  Jennifer C Chang; Nada S Harik; Reiling P Liao; David R Sherman
Journal:  J Infect Dis       Date:  2007-07-13       Impact factor: 5.226

2.  Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is common.

Authors:  Charles W Locuson; J Matthew Hutzler; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2007-01-24       Impact factor: 3.922

3.  Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration.

Authors:  Sruti Shiva; Zhi Huang; Rozalina Grubina; Junhui Sun; Lorna A Ringwood; Peter H MacArthur; Xiuli Xu; Elizabeth Murphy; Victor M Darley-Usmar; Mark T Gladwin
Journal:  Circ Res       Date:  2007-02-09       Impact factor: 17.367

Review 4.  Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis.

Authors:  Kirsty J McLean; Andrew W Munro
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

5.  Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages.

Authors:  Jyothi Rengarajan; Barry R Bloom; Eric J Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

6.  A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages.

Authors:  Robert Van der Geize; Katherine Yam; Thomas Heuser; Maarten H Wilbrink; Hirofumi Hara; Matthew C Anderton; Edith Sim; Lubbert Dijkhuizen; Julian E Davies; William W Mohn; Lindsay D Eltis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

7.  Endothelial nitric oxide synthase reduces nitrite anions to NO under anoxia.

Authors:  Clément Gautier; Ernst van Faassen; Ivan Mikula; Pavel Martasek; Anny Slama-Schwok
Journal:  Biochem Biophys Res Commun       Date:  2006-01-19       Impact factor: 3.575

8.  Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration.

Authors:  Charles D Sohaskey
Journal:  J Bacteriol       Date:  2008-02-22       Impact factor: 3.490

9.  Mycobacterium tuberculosis CYP130: crystal structure, biophysical characterization, and interactions with antifungal azole drugs.

Authors:  Hugues Ouellet; Larissa M Podust; Paul R Ortiz de Montellano
Journal:  J Biol Chem       Date:  2007-12-18       Impact factor: 5.157

10.  Crystal structure of the Mycobacterium tuberculosis P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode.

Authors:  Harriet E Seward; Anna Roujeinikova; Kirsty J McLean; Andrew W Munro; David Leys
Journal:  J Biol Chem       Date:  2006-10-06       Impact factor: 5.157

View more
  25 in total

1.  Substrate analog studies of the ω-regiospecificity of Mycobacterium tuberculosis cholesterol metabolizing cytochrome P450 enzymes CYP124A1, CYP125A1 and CYP142A1.

Authors:  Jonathan B Johnston; Arti A Singh; Anaelle A Clary; Chiung-Kuan Chen; Patricia Y Hayes; Sharon Chow; James J De Voss; Paul R Ortiz de Montellano
Journal:  Bioorg Med Chem       Date:  2012-05-11       Impact factor: 3.641

Review 2.  The Mycobacterium tuberculosis cytochrome P450 system.

Authors:  Hugues Ouellet; Jonathan B Johnston; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2009-07-25       Impact factor: 4.013

3.  The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.

Authors:  Kirsty J McLean; Pierre Lafite; Colin Levy; Myles R Cheesman; Natalia Mast; Irina A Pikuleva; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

4.  Drug modulation of water-heme interactions in low-spin P450 complexes of CYP2C9d and CYP125A1.

Authors:  Kip P Conner; Alex A Cruce; Matthew D Krzyaniak; Alina M Schimpf; Daniel J Frank; Paul Ortiz de Montellano; William M Atkins; Michael K Bowman
Journal:  Biochemistry       Date:  2015-01-29       Impact factor: 3.162

5.  Withdrawn

Authors: 
Journal:  Infect Disord Drug Targets       Date:  2012-11-16

6.  Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease.

Authors:  Edward T Morgan; Cene Skubic; Choon-Myung Lee; Kaja Blagotinšek Cokan; Damjana Rozman
Journal:  Drug Metab Rev       Date:  2020-09-08       Impact factor: 4.518

7.  Nitric oxide blocks cellular heme insertion into a broad range of heme proteins.

Authors:  Syed Mohsin Waheed; Arnab Ghosh; Ritu Chakravarti; Ashis Biswas; Mohammad Mahfuzul Haque; Koustubh Panda; Dennis J Stuehr
Journal:  Free Radic Biol Med       Date:  2010-03-06       Impact factor: 7.376

8.  Mycobacterium tuberculosis CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest-4-en-3-one.

Authors:  Hugues Ouellet; Shenheng Guan; Jonathan B Johnston; Eric D Chow; Petrea M Kells; Alma L Burlingame; Jeffery S Cox; Larissa M Podust; Paul R Ortiz de Montellano
Journal:  Mol Microbiol       Date:  2010-06-10       Impact factor: 3.501

9.  Interaction of Mycobacterium tuberculosis CYP130 with heterocyclic arylamines.

Authors:  Larissa M Podust; Hugues Ouellet; Jens P von Kries; Paul R Ortiz de Montellano
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

10.  Biochemical and structural characterization of CYP124: a methyl-branched lipid omega-hydroxylase from Mycobacterium tuberculosis.

Authors:  Jonathan B Johnston; Petrea M Kells; Larissa M Podust; Paul R Ortiz de Montellano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.